Head-to-head · WeighScore
Bon Health vs TOM Weight Loss
By GLP-1 ScorecardUpdated
Score comparison
Bon Health has the higher recorded score — 69.7/100 to 66.3/100.
Bon Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bon Health shows both the monthly equivalent and the amount billed for each plan length. Ask what happens to unused prepaid money if you stop early.
Before you choose
Before comparing the headline prices, the Bon Health review and the TOM Weight Loss review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Bon Health vs Tonik Wellness and Breeze Meds vs TOM Weight Loss compare each of them with another graded program, and the list of alternatives to Bon Health ranks the programs closest to Bon Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bon Health | TOM Weight Loss |
|---|---|---|
| WeighScore | 69.7/100 | 66.3/100 |
| Grade | C | C |
| Site position | #128 | #211 |
| Semaglutide | $220/mo advertised on monthly billing; $1,140 billed yearly at the $95/mo equivalent | $199/mo (all doses, compounded) |
| Tirzepatide | $285/mo advertised on monthly billing; $1,620 billed yearly at the $135/mo equivalent | $249/mo (all doses, compounded) |
| Coverage | Confirm eligibility for the selected treatment | 2 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Product pages show separate monthly, quarterly, six-month and annual totals
- Product pages advertise no membership fee
- The site identifies its merchant of record
What to consider
- The lowest monthly equivalents require annual billing
- The public site terms do not settle the refund on an unused prepaid balance
- Confirm the assigned pharmacy and selected invoice before paying
Strengths
- ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
- Solo-physician model — every patient sees Dr. Le directly
- Flat-rate pricing — no dose escalation surcharge
- LegitScript badge displayed
- No FDA Warning Letters
What to consider
- Limited geographic footprint — Texas and Utah only
- No named compounding pharmacy partner disclosed
- Compounded medications are not FDA-approved
- Cash-pay only, no insurance
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.